drugset / Trial / NCT03926182

Study to Determine the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Male Volunteers

NCT03926182

Phase 1 Completed 16 enrolled Allist Pharmaceuticals, Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

To assess the Effect of Food on the Blood Levels of AST2818 Following Single Oral Doses in Healthy Male Volunteers in Fasting State or Following a High Fat Meal

Timeline

Start
2019-02-19
Primary completion
2019-04-03
Completion
2019-04-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Firmonertinib Small molecule 80 mg Oral

Indications

No indication recorded.